TGTXTG Therapeutics, Inc.
What is the market doing?
No clear lean: in an uptrend, but a crowded short (+19% of shares).
In an uptrend, above its rising 50- and 200-day averages. Price is +37% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 8, 2026; selling is often routine (taxes, diversification).
A crowded short, settled Sep 15, 2026, more than a week of normal trading to cover, a crowded exit. Level with the previous count, unchanged over three months.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How TGTX is trading
TG Therapeutics, Inc. is +71% over the past year while the S&P 500 is +18%: 53 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +37%
vs 200-day average · a clear uptrend
- RSI (14)
- 44
RSI (14) · neutral
- Below its 52-week high
- 4.7%
Below its 52-week high
Details›
- Last close2026-10-09
- $55.37
- 1 monthS&P 500 +2.7%
- +0.04%
- 1 yearS&P 500 +18%
- +71%
- 5 yearsS&P 500 +88%
- +86%
- vs 50-day average$53.64
- +3.2%
- 52-week high
- $58.12
- 52-week low
- $26.94
- Annualised volatility
- 53%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- −$275K
| Year | Return |
|---|---|
| 2026 (year to date) | +86% |
| 2025 | −0.96% |
| 2024 | +76% |
| 2023 | +44% |
| 2022 | −38% |
| 2021 | −63% |
| 2020 | +369% |
| 2019 | +171% |
| 2018 | −50% |
| 2017 | +76% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 5 of 10 | +5.3% |
| Feb | 10 | 6 of 10 | +7.9% |
| Mar | 10 | 6 of 10 | +13% |
| Apr | 10 | 5 of 10 | +5.2% |
| May | 10 | 5 of 10 | −0.96% |
| Jun | 10 | 6 of 10 | +8.4% |
| Jul | 11 | 5 of 11 | +1.4% |
| Aug | 11 | 6 of 11 | −1.5% |
| Sep | 11 | 5 of 11 | −2.8% |
| Oct | 11 | 2 of 11 | −7.0% |
| Nov | 10 | 8 of 10 | +16% |
| Dec | 10 | 5 of 10 | +14% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.